Boardroom Alpha
Boardroom Alpha
DCO · Current Report (Form 8-K) · Filed December 1, 2025

Ducommun Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 1, 2025
Period
Nov 24, 2025
Ticker
DCO
Accession
0001193125-25-303948
Boardroom Alpha · Filing insights

Ducommun amended its credit agreements, adding $200M term loan and $450M revolver; proceeds sourced prepay debt and fund working capital.

About Ducommun Inc
Market cap
$2.3B
1Y TSR
+88.6%
3Y TSR
+48.7%
Board grade
A-
Sector
Industrials
CEO
Stephen G Oswald
Last annual meeting: Apr 29, 2026 · View full Ducommun Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 24, 2025

 

 

DUCOMMUN INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-08174   95-0693330
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

600 Anton Blvd., Suite 1100,  
Costa Mesa, California   92626-7100
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (657) 335-3665

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $.01 par value per share   DCO   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into a Material Definitive Agreement.

On November 24, 2025 (the “Closing Date”) Ducommun Incorporated, a Delaware corporation (“Ducommun”) and certain of its subsidiaries entered into a First Amendment to Credit Agreement, Security Agreement and Pledge Agreement with Bank of America, N.A., as administrative agent, swingline lender and an L/C issuer, and the lender parties thereto (the “Amendment”). The Amendment, among other things, made certain amendments to that certain Credit Agreement, dated as of July 14, 2022 (the “Existing Credit Agreement” and as amended by the Amendment, the “Amended Credit Agreement”) among Ducommun, certain subsidiaries of Ducommun party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent, swingline lender and an L/C issuer.

The Amended Credit Agreement provides for (i) a five-year $200 million senior secured term loan facility (the “Term Loan Facility”), all of which was drawn on the Closing Date and (ii) a five-year $450 million senior secured revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Facilities”), of which $120 million was drawn on the Closing Date. The Revolving Credit Facility includes a $30 million sublimit for the issuance of standby and commercial letters of credit and a $15 million swingline subfacility.

Ducommun used the proceeds of the borrowings made on the Closing Date under the Revolving Credit Facility to prepay a portion of the outstanding term loan and accrued and unpaid interest thereon under the Existing Credit Agreement and to pay all related fees and expenses. Additionally, Ducommun intends to use the proceeds to fund working capital and for other general corporate expenses.

Ducommun has the option to request the addition of one or more incremental term loan facilities or the increase of commitments under the Revolving Credit Facility by (i) up to the greater of (a) $125 million and (b) 100% of consolidated EBITDA for the most recently completed four fiscal quarters plus (ii) such amounts as would not cause the consolidated first lien net adjusted leverage ratio, determined on a pro forma basis after giving effect to any such additions and increases, to exceed 4.00:1.00, which additions and increases are subject to the satisfaction of certain conditions set forth in the Amended Credit Agreement.

The initial variable interest rate on amounts outstanding under the Facilities will be Term SOFR plus 1.50%, subject to adjustments based on Ducommun’s consolidated total net adjusted leverage ratio.

Ducommun’s obligations under the Amended Credit Agreement and any hedging or cash management obligations entered into by Ducommun or any of its current and future material domestic restricted subsidiaries (the “Subsidiary Guarantors” and, together with Ducommun, the “Loan Parties”) with a lender under the Amended Credit Agreement or an affiliate of such lender are guaranteed by Ducommun and each such Subsidiary Guarantor. Ducommun’s and the Subsidiary Guarantors’ obligations under the Amended Credit Agreement are secured by substantially all of their assets, subject to certain customary exceptions.

Ducommun is required to make payments of amounts outstanding under the Amended Credit Agreement (without payment of a premium or penalty) with (i) 100% of the net cash proceeds received from certain non-ordinary course asset sales, dispositions and extraordinary proceeds in excess of agreed upon thresholds, subject to certain reinvestment rights and repatriation issues and (ii) 100% of the net cash proceeds received by Ducommun or any of its restricted subsidiaries from the issuance of any indebtedness (other than indebtedness permitted to be incurred under the Amended Credit Agreement). The loans under the Term Loan Facility will amortize in quarterly installments, equal to 2.50% per annum of the original aggregate principal amount thereof during the first two years, 5.00% per annum of the original aggregate principal amount thereof during the next two years and 7.50% per annum of the original aggregate principal amount thereof during the final year with the remaining balance payable on November 24, 2030. The loans under the Revolving Credit Facility are due on November 24, 2030.

The Amended Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Loan Parties and the restricted subsidiaries of Ducommun, including, without limitation, restrictions on liens, indebtedness, investments, fundamental changes, dispositions, restricted payments and prepayment of junior indebtedness. The Amended Credit Agreement contains financial covenants that require the Loan Parties and restricted subsidiaries of Ducommun to (i) not exceed a maximum consolidated total net adjusted leverage ratio initially set at 4.75:1.00, which, at Ducommun’s option, may increase up to 5.25:1.00 for certain permitted acquisitions and (ii) maintain a consolidated interest coverage ratio of at least 2.00:1.00.

The Amended Credit Agreement contains customary events of default, including, without limitation, payment defaults, covenant defaults, breaches of certain representations and warranties, cross defaults to certain material indebtedness, certain events of bankruptcy and insolvency, certain events under ERISA, material judgments and change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the lenders are entitled to take various actions, including, without limitation, the acceleration of amounts due thereunder and termination of commitments under the Facilities.

The foregoing description of the Amendment is not intended to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

See Item 1.01 above, which is incorporated by reference herein.

 

Item 8.01

Other Events

In connection with the entry into the Amendment, Ducommun issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    DUCOMMUN INCORPORATED
    (Registrant)
Date: December 1, 2025     By:  

/s/ Suman B. Mookerji

      Suman B. Mookerji
      Senior Vice President, Chief Financial Officer
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Ducommun Inc (DCO)

Reference

Frequently asked questions

When did Ducommun Inc file this 8-K?
Ducommun Inc (DCO) filed this Current Report (Form 8-K) with the SEC on December 1, 2025. The accession number assigned by EDGAR is 0001193125-25-303948.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Ducommun amended its credit agreements, adding $200M term loan and $450M revolver; proceeds sourced prepay debt and fund working capital. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Ducommun Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Ducommun Inc has filed under CIK 30305, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer